insights_auto
Why is TCRX down 4.40%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
$0.16
arrow_downward
-4.40%(-0.0074) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
10.76M
Avg. vol.
547.00K
Volume
0.00
52-wk high
$1.47
52-wk low
$0.16
EPS
-$0.89
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
10.76M
Avg. vol.
547.00K
Volume
0.00
52-wk high
$1.47
52-wk low
$0.16
EPS
-$0.89
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
News stories
From web sources and news partners
marketscreener.com
·
42 minutes ago
Live Oak Acquisition Corp. VI(NasdaqGM: LOVI) added to NASDAQ Composite Index
Cryptonews.net
·
8 minutes ago
Drakewell Introduces Hedged S&P 500 Token
US News Money
·
30 minutes ago
S&P 500, Nasdaq Futures Slide as Nvidia Earnings, Anthropic Debut Loom
Business Insider
·
1 hour ago
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitetscan.com